Exponent, Inc. (EXPO) EPS Estimated At $0.60

June 20, 2018 - By Ash Ash

Exponent, Inc. (NASDAQ:EXPO) LogoInvestors sentiment decreased to 1.31 in 2018 Q1. Its down 0.35, from 1.66 in 2017Q4. It dived, as 14 investors sold Exponent, Inc. shares while 56 reduced holdings. 24 funds opened positions while 68 raised stakes. 22.31 million shares or 0.02% less from 22.32 million shares in 2017Q4 were reported.
Alphaone Inv Ltd Com has 1.01% invested in Exponent, Inc. (NASDAQ:EXPO) for 46,523 shares. Cordasco Fincl Networks accumulated 9,113 shares. 19,381 were accumulated by Confluence Inv Mgmt Limited Co. First Tru Advsrs Ltd Partnership holds 54,677 shares. Axiom Intl Investors Ltd Com De accumulated 56,427 shares. Archford Capital Strategies Limited Liability Corp invested in 50 shares or 0% of the stock. Fifth Third Bancshares reported 673 shares. Tower Rech Capital (Trc) has 0% invested in Exponent, Inc. (NASDAQ:EXPO) for 462 shares. Point72 Asia (Hong Kong) Limited reported 23 shares. Principal Gru Inc stated it has 0.02% in Exponent, Inc. (NASDAQ:EXPO). Texas-based Dimensional Fund Advisors Limited Partnership has invested 0.03% in Exponent, Inc. (NASDAQ:EXPO). Neuberger Berman Gp Limited Liability holds 2.06 million shares or 0.19% of its portfolio. Architects Inc holds 0% of its portfolio in Exponent, Inc. (NASDAQ:EXPO) for 166 shares. Envestnet Asset Inc has 0% invested in Exponent, Inc. (NASDAQ:EXPO). Prudential Fincl Incorporated invested 0.01% of its portfolio in Exponent, Inc. (NASDAQ:EXPO).

Since May 7, 2018, it had 0 insider purchases, and 6 selling transactions for $3.78 million activity. On Friday, May 25 Zumwalt Debra sold $48,004 worth of Exponent, Inc. (NASDAQ:EXPO) or 500 shares. 4,449 shares valued at $398,332 were sold by Corrigan Catherine on Friday, May 11. $2.57 million worth of stock was sold by SCHLENKER RICHARD L JR on Monday, May 7. $248,161 worth of Exponent, Inc. (NASDAQ:EXPO) was sold by Kytomaa Harri on Friday, May 18.

Analysts expect Exponent, Inc. (NASDAQ:EXPO) to report $0.60 EPS on July, 17.They anticipate $0.09 EPS change or 17.65 % from last quarter’s $0.51 EPS. EXPO’s profit would be $15.61 million giving it 21.06 P/E if the $0.60 EPS is correct. After having $0.61 EPS previously, Exponent, Inc.’s analysts see -1.64 % EPS growth. The stock increased 0.10% or $0.05 during the last trading session, reaching $50.55. About 137,314 shares traded. Exponent, Inc. (NASDAQ:EXPO) has risen 61.24% since June 20, 2017 and is uptrending. It has outperformed by 48.67% the S&P500.

Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting firm worldwide. The company has market cap of $1.32 billion. The Company’s services include analysis of product development, product recall, regulatory compliance, and the discovery of potential problems related to products, people, property, and impending litigation. It has a 60.54 P/E ratio. The firm operates in two divisions, Engineering and Other Scientific, and Environmental and Health.

Exponent, Inc. (NASDAQ:EXPO) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: